Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSysgroup Regulatory News (SYS)

Share Price Information for Sysgroup (SYS)

Share Price is delayed by 15 minutes
Get Live Data
18.00    0.00 (0.00%)
Bid:
17.00
Ask:
19.00
Spread: 2.00 (11.765%)
Market Cap: £15.07m
SYS Live PriceLast checked at - London Stock Exchange

Intraday Sysgroup Share Chart

Trading Statement

15 Jun 2010 07:00

RNS Number : 6027N
System C Healthcare plc
15 June 2010
 



 

System C Healthcare PLC

 

Pre-Close Trading Update - Year ended 31 May 2010

 

15th June 2010

 

System C Healthcare plc (AIM:SYS) ("System C" or "the Company"), a leading provider of information solutions and services to the health and social care sector, is pleased to provide the following trading update for financial year ended 31 May 2010.

 

System C expects to report an increase in annual revenue of some 75%, compared with the previous year. This includes substantial organic growth. Profits before tax are expected to be in-line with current market expectations of £5.4m for the year ended 31 May 2010 (2009: £4.1m). Despite tougher trading conditions, the medium-term prospects are considerable and the Board remains confident that strategic plans in place will enable the Company to capitalise on the substantial opportunities ahead, including a number of Trust-wide procurement processes in which it is currently involved.

 

Products

The group's business continues to shift towards the Products Division, in line with the stated strategy to diversify its revenue streams. System C's Medway product suite continues to develop and deliver well, with a number of important milestones achieved. The implementation of the Medway clinical information system at Aintree University Hospital NHS Foundation Trust has progressed well and according to expectations, which should act as an important reference site for our Electronic Patient Record System. Following this success, the Company announced on 12 May 2010 that it had been selected by The Royal Devon & Exeter NHS Foundation Trust to supply its Medway order communications and electronic-prescribing software. This represents a significant strategic win in one of the first major procurements outside the Government's National Programme for IT.

 

Other recent product installations have included multiple deployments of the Company's clinical dashboard, web portal, maternity, accident and emergency, and other departmental modules. The latter stages of the deployment of a wide range of health and social care systems on behalf of the Isle of Man Government have also gone to plan, and it is expected that this large-scale programme will be completed successfully by August 2010.

 

Liquidlogic, acquired in July 2009, has begun integrating its product and marketing efforts with System C's healthcare ranges and has made its first sale of a Medway dashboard to a social care client. System C and Liquidlogic have also produced the UK's first health and social care link under NHS Connecting for Health's (CfH) new standards for systems integration. The procurement pipeline for social care systems is strong with ten active procurements in progress, and procurements are running at more than twice the rate of 2009/10.

 

Services

Services revenues for the year ended 31 May 2010 are comparable to the previous year. The Company continues to deploy a wide range of third party systems for NHS trusts across the UK. The Company remains heavily involved in deploying third party products from iSoft and Cerner under the National Programme for IT, with both CfH and Local Service Providers as clients. System C staff have been involved with many of the major acute system go-lives this year, including Lorenzo and Cerner Millennium deployments. Our Healthcare Improvement team continues to deliver results with a number of contracts wins at NHS Trusts in England and in Northern Ireland.

 

Outlook

The market for IT products in the NHS is now opening up to a wider range of suppliers, and with its substantial five year strategic investment in its Medway product suite, System C is well placed to take advantage of this change. The Company is already experiencing a significant increase in interest for its hospital products and is active in a number of procurements. Negotiation periods for these large scale contracts are inevitably long-term in nature and revenues from sales of the new hospital-wide system are expected to come on stream in the second half of the current financial year and beyond.

 

The Directors recognise that in the short term, government spending cuts present a risk to revenues, particularly services revenues. The timing of NHS procurements and deployments will have a significant impact on the Company's performance during the current year as System C continues its transition into a product-led company. During this period the Company will be focused in particular on cash management to ensure that costs remain in line with the revenue streams. As at 31 May 2010 the Company had net cash balances of approximately £18.6 million.

 

The Board considers there to be significant product opportunities in the medium term, which will lead to greater visibility of contract revenues, improved margins and increased predictability in services utilisation.

 

For further information please contact:

 

System C Healthcare plc

 

Dr Ian Denley, Chief Executive

Tel: 01622 691616

Thomas Chambers, Acting Finance Director

 

 

 

Charles Stanley Securities (Nominated Adviser)

Tel: 020 7149 6000

Russell Cook/Mark Taylor

 

 

 

Maitland (Financial and Corporate Communications)

Tel: 020 7379 5151

Emma Burdett/Tom Eckersley

 

 

Notes to editors:

System C Healthcare plc (www.systemc.com), specialises in the design and development of clinical patient management and business intelligence software, and provides systems implementation and consulting services to the health and social care sectors. 

 

System C Healthcare is quoted on the London Stock Exchange's Alternative Investment Market.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTBIGDLRUBBGGS
Date   Source Headline
19th May 20267:00 amRNSChange of Registered Office
13th Apr 20267:00 amRNSYear End Trading Update
13th Mar 202610:11 amRNSTransfer of Shares to AI Board Adviser and TVR
13th Mar 202610:11 amRNSTransfer of Shares to AI Board Adviser and TVR
9th Feb 202610:15 amRNS-RIT Infrastructure Refresh Contract Win
3rd Feb 20264:13 pmRNSDirector/PDMR Dealing
29th Jan 20262:11 pmRNS-RContract win with the Scouts Association
22nd Jan 20269:34 amRNSHolding(s) in Company
22nd Dec 20252:08 pmRNSAcquisition of Saxis Group Limited
22nd Dec 20252:08 pmRNSAcquisition of Saxis Group Limited
9th Dec 202512:06 pmRNS-RAppointment of AI Adviser
3rd Dec 20257:00 amRNSHalf Year Results to 30 September 2025
25th Nov 20257:00 amRNSNotice of Results
16th Sep 20253:38 pmRNSResult of AGM
12th Sep 202510:51 amRNSDirector Dealing
8th Sep 202512:17 pmRNSExercise of Options and Total Voting Rights
3rd Sep 20257:00 amRNSGrant of Options and PDMR Dealings
8th Aug 20257:00 amRNSNotice of AGM and Publication of Accounts
29th Jul 202510:17 amRNSDirector/PDMR Dealing
24th Jul 20257:00 amRNSFinal Results for the year ended 31 March 2025
14th Jul 20257:00 amRNSNotice of Results
29th Apr 20257:00 amRNSYear End Trading Update
20th Mar 202511:34 amRNS-RSysGroup Joins Rubrik's Advanced Partner Program
29th Jan 20259:17 amRNSHolding(s) in Company
28th Jan 20257:00 amRNSDirector/PDMR Dealing
22nd Jan 20257:00 amRNSHolding(s) in Company
19th Dec 202412:45 pmRNSExercise of Options and Total Voting Rights
4th Dec 20244:00 pmRNSPresentation via Investor Meet Company
3rd Dec 20241:00 pmRNSDirector/PDMR Dealing
3rd Dec 20247:00 amRNSHalf Year Results to 30 September 2024
19th Nov 20247:00 amRNSAcquisition & Notice of Results
20th Sep 202411:00 amRNSResult of AGM
12th Sep 20247:00 amRNSAIM Rule 17 and Schedule 2(g) Disclosure
3rd Sep 20247:00 amRNSGrant of Options and Director/PDMR Dealings
21st Aug 20244:50 pmRNSGrant of Options and Director/PDMR Dealings
15th Aug 20247:00 amRNSNotice of AGM and Publication of Annual Report
31st Jul 20247:00 amRNSFinal Results for the year ended 31 March 2024
24th Jul 20247:00 amRNSNotice of Results
28th Jun 202410:10 amRNSHolding(s) in Company
28th Jun 20247:00 amRNSHolding(s) in Company
24th Jun 20244:12 pmRNSResult of General Meeting and Total Voting Rights
14th Jun 20247:00 amRNSResult of Retail Offer
7th Jun 20248:00 amRNSLaunch of Retail Offer
7th Jun 20247:00 amRNSResult of Oversubscribed Placing and Subscription
6th Jun 20245:11 pmRNSProposed Fundraising
3rd Jun 20247:00 amRNSBoard Changes
29th May 20247:00 amRNSStrategic Partnership
30th Apr 20247:00 amRNSTrading Update
29th Feb 20248:49 amRNSHolding(s) in Company
29th Feb 20247:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.